Global Needle-free Drug Injectors Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Needle-free Drug Injectors market size was valued at US$ 242 million in 2024 and is forecast to a readjusted size of USD 337 million by 2031 with a CAGR of 4.9% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
This report is a detailed and comprehensive analysis for global Needle-free Drug Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Needle-free Drug Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Needle-free Drug Injectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Needle-free Drug Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Needle-free Drug Injectors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Needle-free Drug Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Needle-free Drug Injectors, with price, sales quantity, revenue, and global market share of Needle-free Drug Injectors from 2020 to 2025.
Chapter 3, the Needle-free Drug Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-free Drug Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Needle-free Drug Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Needle-free Drug Injectors.
Chapter 14 and 15, to describe Needle-free Drug Injectors sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Needle-free drug injectors are advanced drug delivery technologies that dispense with the use of traditional syringes and needles in favor of the rapid delivery of drugs to subcutaneous or muscular tissues by means of high-speed liquid streams or other means that penetrate directly into the skin. These systems typically employ the high-pressure injection principle, which utilizes a compressed gas or spring-loaded device to generate sufficient pressure to allow the liquid drug to penetrate the skin barrier and enter the body in the form of an extremely fine, high-speed stream. Needle-free drug injectors are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
This report is a detailed and comprehensive analysis for global Needle-free Drug Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Needle-free Drug Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Needle-free Drug Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Needle-free Drug Injectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Needle-free Drug Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Halozyme (Antares Pharma), Inovio Pharmaceuticals, Endo International, Injex Pharma GmbH, National Medical Products (J-Tip), Recipharm, InsuJet, Miracle Medical, Medical International Technology (MIT), Akra Dermojet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Needle-free Drug Injectors market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Powder Injections
- Liquid Injections
- Depot or Projectile Injection
- Vaccine Delivery
- Insulin Delivery
- Others
- Halozyme (Antares Pharma)
- Inovio Pharmaceuticals
- Endo International
- Injex Pharma GmbH
- National Medical Products (J-Tip)
- Recipharm
- InsuJet
- Miracle Medical
- Medical International Technology (MIT)
- Akra Dermojet
- PharmaJet
- Portal Instruments
- Crossject
- Mika Medical
- Ferring Pharmaceuticals
- IntegriMedical
- Helcomin
- Nugen Medical
- Lepu Medical
- Beijing Quinovare
- Qingdao Zhonghui Health Industrial Group
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Needle-free Drug Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Needle-free Drug Injectors, with price, sales quantity, revenue, and global market share of Needle-free Drug Injectors from 2020 to 2025.
Chapter 3, the Needle-free Drug Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Needle-free Drug Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Needle-free Drug Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Needle-free Drug Injectors.
Chapter 14 and 15, to describe Needle-free Drug Injectors sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Needle-free Drug Injectors Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Powder Injections
1.3.3 Liquid Injections
1.3.4 Depot or Projectile Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Needle-free Drug Injectors Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Vaccine Delivery
1.4.3 Insulin Delivery
1.4.4 Others
1.5 Global Needle-free Drug Injectors Market Size & Forecast
1.5.1 Global Needle-free Drug Injectors Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Needle-free Drug Injectors Sales Quantity (2020-2031)
1.5.3 Global Needle-free Drug Injectors Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Halozyme (Antares Pharma)
2.1.1 Halozyme (Antares Pharma) Details
2.1.2 Halozyme (Antares Pharma) Major Business
2.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Product and Services
2.1.4 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Halozyme (Antares Pharma) Recent Developments/Updates
2.2 Inovio Pharmaceuticals
2.2.1 Inovio Pharmaceuticals Details
2.2.2 Inovio Pharmaceuticals Major Business
2.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Product and Services
2.2.4 Inovio Pharmaceuticals Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Inovio Pharmaceuticals Recent Developments/Updates
2.3 Endo International
2.3.1 Endo International Details
2.3.2 Endo International Major Business
2.3.3 Endo International Needle-free Drug Injectors Product and Services
2.3.4 Endo International Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Endo International Recent Developments/Updates
2.4 Injex Pharma GmbH
2.4.1 Injex Pharma GmbH Details
2.4.2 Injex Pharma GmbH Major Business
2.4.3 Injex Pharma GmbH Needle-free Drug Injectors Product and Services
2.4.4 Injex Pharma GmbH Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Injex Pharma GmbH Recent Developments/Updates
2.5 National Medical Products (J-Tip)
2.5.1 National Medical Products (J-Tip) Details
2.5.2 National Medical Products (J-Tip) Major Business
2.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Product and Services
2.5.4 National Medical Products (J-Tip) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 National Medical Products (J-Tip) Recent Developments/Updates
2.6 Recipharm
2.6.1 Recipharm Details
2.6.2 Recipharm Major Business
2.6.3 Recipharm Needle-free Drug Injectors Product and Services
2.6.4 Recipharm Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Recipharm Recent Developments/Updates
2.7 InsuJet
2.7.1 InsuJet Details
2.7.2 InsuJet Major Business
2.7.3 InsuJet Needle-free Drug Injectors Product and Services
2.7.4 InsuJet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 InsuJet Recent Developments/Updates
2.8 Miracle Medical
2.8.1 Miracle Medical Details
2.8.2 Miracle Medical Major Business
2.8.3 Miracle Medical Needle-free Drug Injectors Product and Services
2.8.4 Miracle Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Miracle Medical Recent Developments/Updates
2.9 Medical International Technology (MIT)
2.9.1 Medical International Technology (MIT) Details
2.9.2 Medical International Technology (MIT) Major Business
2.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Product and Services
2.9.4 Medical International Technology (MIT) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Medical International Technology (MIT) Recent Developments/Updates
2.10 Akra Dermojet
2.10.1 Akra Dermojet Details
2.10.2 Akra Dermojet Major Business
2.10.3 Akra Dermojet Needle-free Drug Injectors Product and Services
2.10.4 Akra Dermojet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Akra Dermojet Recent Developments/Updates
2.11 PharmaJet
2.11.1 PharmaJet Details
2.11.2 PharmaJet Major Business
2.11.3 PharmaJet Needle-free Drug Injectors Product and Services
2.11.4 PharmaJet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 PharmaJet Recent Developments/Updates
2.12 Portal Instruments
2.12.1 Portal Instruments Details
2.12.2 Portal Instruments Major Business
2.12.3 Portal Instruments Needle-free Drug Injectors Product and Services
2.12.4 Portal Instruments Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Portal Instruments Recent Developments/Updates
2.13 Crossject
2.13.1 Crossject Details
2.13.2 Crossject Major Business
2.13.3 Crossject Needle-free Drug Injectors Product and Services
2.13.4 Crossject Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Crossject Recent Developments/Updates
2.14 Mika Medical
2.14.1 Mika Medical Details
2.14.2 Mika Medical Major Business
2.14.3 Mika Medical Needle-free Drug Injectors Product and Services
2.14.4 Mika Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Mika Medical Recent Developments/Updates
2.15 Ferring Pharmaceuticals
2.15.1 Ferring Pharmaceuticals Details
2.15.2 Ferring Pharmaceuticals Major Business
2.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Product and Services
2.15.4 Ferring Pharmaceuticals Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Ferring Pharmaceuticals Recent Developments/Updates
2.16 IntegriMedical
2.16.1 IntegriMedical Details
2.16.2 IntegriMedical Major Business
2.16.3 IntegriMedical Needle-free Drug Injectors Product and Services
2.16.4 IntegriMedical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 IntegriMedical Recent Developments/Updates
2.17 Helcomin
2.17.1 Helcomin Details
2.17.2 Helcomin Major Business
2.17.3 Helcomin Needle-free Drug Injectors Product and Services
2.17.4 Helcomin Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Helcomin Recent Developments/Updates
2.18 Nugen Medical
2.18.1 Nugen Medical Details
2.18.2 Nugen Medical Major Business
2.18.3 Nugen Medical Needle-free Drug Injectors Product and Services
2.18.4 Nugen Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Nugen Medical Recent Developments/Updates
2.19 Lepu Medical
2.19.1 Lepu Medical Details
2.19.2 Lepu Medical Major Business
2.19.3 Lepu Medical Needle-free Drug Injectors Product and Services
2.19.4 Lepu Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Lepu Medical Recent Developments/Updates
2.20 Beijing Quinovare
2.20.1 Beijing Quinovare Details
2.20.2 Beijing Quinovare Major Business
2.20.3 Beijing Quinovare Needle-free Drug Injectors Product and Services
2.20.4 Beijing Quinovare Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Beijing Quinovare Recent Developments/Updates
2.21 Qingdao Zhonghui Health Industrial Group
2.21.1 Qingdao Zhonghui Health Industrial Group Details
2.21.2 Qingdao Zhonghui Health Industrial Group Major Business
2.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product and Services
2.21.4 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEEDLE-FREE DRUG INJECTORS BY MANUFACTURER
3.1 Global Needle-free Drug Injectors Sales Quantity by Manufacturer (2020-2025)
3.2 Global Needle-free Drug Injectors Revenue by Manufacturer (2020-2025)
3.3 Global Needle-free Drug Injectors Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Needle-free Drug Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Needle-free Drug Injectors Manufacturer Market Share in 2024
3.4.3 Top 6 Needle-free Drug Injectors Manufacturer Market Share in 2024
3.5 Needle-free Drug Injectors Market: Overall Company Footprint Analysis
3.5.1 Needle-free Drug Injectors Market: Region Footprint
3.5.2 Needle-free Drug Injectors Market: Company Product Type Footprint
3.5.3 Needle-free Drug Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Needle-free Drug Injectors Market Size by Region
4.1.1 Global Needle-free Drug Injectors Sales Quantity by Region (2020-2031)
4.1.2 Global Needle-free Drug Injectors Consumption Value by Region (2020-2031)
4.1.3 Global Needle-free Drug Injectors Average Price by Region (2020-2031)
4.2 North America Needle-free Drug Injectors Consumption Value (2020-2031)
4.3 Europe Needle-free Drug Injectors Consumption Value (2020-2031)
4.4 Asia-Pacific Needle-free Drug Injectors Consumption Value (2020-2031)
4.5 South America Needle-free Drug Injectors Consumption Value (2020-2031)
4.6 Middle East & Africa Needle-free Drug Injectors Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
5.2 Global Needle-free Drug Injectors Consumption Value by Type (2020-2031)
5.3 Global Needle-free Drug Injectors Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
6.2 Global Needle-free Drug Injectors Consumption Value by Application (2020-2031)
6.3 Global Needle-free Drug Injectors Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
7.2 North America Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
7.3 North America Needle-free Drug Injectors Market Size by Country
7.3.1 North America Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
7.3.2 North America Needle-free Drug Injectors Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
8.2 Europe Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
8.3 Europe Needle-free Drug Injectors Market Size by Country
8.3.1 Europe Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
8.3.2 Europe Needle-free Drug Injectors Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Needle-free Drug Injectors Market Size by Region
9.3.1 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
10.2 South America Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
10.3 South America Needle-free Drug Injectors Market Size by Country
10.3.1 South America Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
10.3.2 South America Needle-free Drug Injectors Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Needle-free Drug Injectors Market Size by Country
11.3.1 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Needle-free Drug Injectors Market Drivers
12.2 Needle-free Drug Injectors Market Restraints
12.3 Needle-free Drug Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Needle-free Drug Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Needle-free Drug Injectors
13.3 Needle-free Drug Injectors Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Needle-free Drug Injectors Typical Distributors
14.3 Needle-free Drug Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Needle-free Drug Injectors Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Powder Injections
1.3.3 Liquid Injections
1.3.4 Depot or Projectile Injection
1.4 Market Analysis by Application
1.4.1 Overview: Global Needle-free Drug Injectors Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Vaccine Delivery
1.4.3 Insulin Delivery
1.4.4 Others
1.5 Global Needle-free Drug Injectors Market Size & Forecast
1.5.1 Global Needle-free Drug Injectors Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Needle-free Drug Injectors Sales Quantity (2020-2031)
1.5.3 Global Needle-free Drug Injectors Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Halozyme (Antares Pharma)
2.1.1 Halozyme (Antares Pharma) Details
2.1.2 Halozyme (Antares Pharma) Major Business
2.1.3 Halozyme (Antares Pharma) Needle-free Drug Injectors Product and Services
2.1.4 Halozyme (Antares Pharma) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Halozyme (Antares Pharma) Recent Developments/Updates
2.2 Inovio Pharmaceuticals
2.2.1 Inovio Pharmaceuticals Details
2.2.2 Inovio Pharmaceuticals Major Business
2.2.3 Inovio Pharmaceuticals Needle-free Drug Injectors Product and Services
2.2.4 Inovio Pharmaceuticals Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Inovio Pharmaceuticals Recent Developments/Updates
2.3 Endo International
2.3.1 Endo International Details
2.3.2 Endo International Major Business
2.3.3 Endo International Needle-free Drug Injectors Product and Services
2.3.4 Endo International Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Endo International Recent Developments/Updates
2.4 Injex Pharma GmbH
2.4.1 Injex Pharma GmbH Details
2.4.2 Injex Pharma GmbH Major Business
2.4.3 Injex Pharma GmbH Needle-free Drug Injectors Product and Services
2.4.4 Injex Pharma GmbH Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Injex Pharma GmbH Recent Developments/Updates
2.5 National Medical Products (J-Tip)
2.5.1 National Medical Products (J-Tip) Details
2.5.2 National Medical Products (J-Tip) Major Business
2.5.3 National Medical Products (J-Tip) Needle-free Drug Injectors Product and Services
2.5.4 National Medical Products (J-Tip) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 National Medical Products (J-Tip) Recent Developments/Updates
2.6 Recipharm
2.6.1 Recipharm Details
2.6.2 Recipharm Major Business
2.6.3 Recipharm Needle-free Drug Injectors Product and Services
2.6.4 Recipharm Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Recipharm Recent Developments/Updates
2.7 InsuJet
2.7.1 InsuJet Details
2.7.2 InsuJet Major Business
2.7.3 InsuJet Needle-free Drug Injectors Product and Services
2.7.4 InsuJet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 InsuJet Recent Developments/Updates
2.8 Miracle Medical
2.8.1 Miracle Medical Details
2.8.2 Miracle Medical Major Business
2.8.3 Miracle Medical Needle-free Drug Injectors Product and Services
2.8.4 Miracle Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Miracle Medical Recent Developments/Updates
2.9 Medical International Technology (MIT)
2.9.1 Medical International Technology (MIT) Details
2.9.2 Medical International Technology (MIT) Major Business
2.9.3 Medical International Technology (MIT) Needle-free Drug Injectors Product and Services
2.9.4 Medical International Technology (MIT) Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Medical International Technology (MIT) Recent Developments/Updates
2.10 Akra Dermojet
2.10.1 Akra Dermojet Details
2.10.2 Akra Dermojet Major Business
2.10.3 Akra Dermojet Needle-free Drug Injectors Product and Services
2.10.4 Akra Dermojet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Akra Dermojet Recent Developments/Updates
2.11 PharmaJet
2.11.1 PharmaJet Details
2.11.2 PharmaJet Major Business
2.11.3 PharmaJet Needle-free Drug Injectors Product and Services
2.11.4 PharmaJet Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 PharmaJet Recent Developments/Updates
2.12 Portal Instruments
2.12.1 Portal Instruments Details
2.12.2 Portal Instruments Major Business
2.12.3 Portal Instruments Needle-free Drug Injectors Product and Services
2.12.4 Portal Instruments Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Portal Instruments Recent Developments/Updates
2.13 Crossject
2.13.1 Crossject Details
2.13.2 Crossject Major Business
2.13.3 Crossject Needle-free Drug Injectors Product and Services
2.13.4 Crossject Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Crossject Recent Developments/Updates
2.14 Mika Medical
2.14.1 Mika Medical Details
2.14.2 Mika Medical Major Business
2.14.3 Mika Medical Needle-free Drug Injectors Product and Services
2.14.4 Mika Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Mika Medical Recent Developments/Updates
2.15 Ferring Pharmaceuticals
2.15.1 Ferring Pharmaceuticals Details
2.15.2 Ferring Pharmaceuticals Major Business
2.15.3 Ferring Pharmaceuticals Needle-free Drug Injectors Product and Services
2.15.4 Ferring Pharmaceuticals Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Ferring Pharmaceuticals Recent Developments/Updates
2.16 IntegriMedical
2.16.1 IntegriMedical Details
2.16.2 IntegriMedical Major Business
2.16.3 IntegriMedical Needle-free Drug Injectors Product and Services
2.16.4 IntegriMedical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 IntegriMedical Recent Developments/Updates
2.17 Helcomin
2.17.1 Helcomin Details
2.17.2 Helcomin Major Business
2.17.3 Helcomin Needle-free Drug Injectors Product and Services
2.17.4 Helcomin Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Helcomin Recent Developments/Updates
2.18 Nugen Medical
2.18.1 Nugen Medical Details
2.18.2 Nugen Medical Major Business
2.18.3 Nugen Medical Needle-free Drug Injectors Product and Services
2.18.4 Nugen Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Nugen Medical Recent Developments/Updates
2.19 Lepu Medical
2.19.1 Lepu Medical Details
2.19.2 Lepu Medical Major Business
2.19.3 Lepu Medical Needle-free Drug Injectors Product and Services
2.19.4 Lepu Medical Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Lepu Medical Recent Developments/Updates
2.20 Beijing Quinovare
2.20.1 Beijing Quinovare Details
2.20.2 Beijing Quinovare Major Business
2.20.3 Beijing Quinovare Needle-free Drug Injectors Product and Services
2.20.4 Beijing Quinovare Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 Beijing Quinovare Recent Developments/Updates
2.21 Qingdao Zhonghui Health Industrial Group
2.21.1 Qingdao Zhonghui Health Industrial Group Details
2.21.2 Qingdao Zhonghui Health Industrial Group Major Business
2.21.3 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product and Services
2.21.4 Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: NEEDLE-FREE DRUG INJECTORS BY MANUFACTURER
3.1 Global Needle-free Drug Injectors Sales Quantity by Manufacturer (2020-2025)
3.2 Global Needle-free Drug Injectors Revenue by Manufacturer (2020-2025)
3.3 Global Needle-free Drug Injectors Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Needle-free Drug Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Needle-free Drug Injectors Manufacturer Market Share in 2024
3.4.3 Top 6 Needle-free Drug Injectors Manufacturer Market Share in 2024
3.5 Needle-free Drug Injectors Market: Overall Company Footprint Analysis
3.5.1 Needle-free Drug Injectors Market: Region Footprint
3.5.2 Needle-free Drug Injectors Market: Company Product Type Footprint
3.5.3 Needle-free Drug Injectors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Needle-free Drug Injectors Market Size by Region
4.1.1 Global Needle-free Drug Injectors Sales Quantity by Region (2020-2031)
4.1.2 Global Needle-free Drug Injectors Consumption Value by Region (2020-2031)
4.1.3 Global Needle-free Drug Injectors Average Price by Region (2020-2031)
4.2 North America Needle-free Drug Injectors Consumption Value (2020-2031)
4.3 Europe Needle-free Drug Injectors Consumption Value (2020-2031)
4.4 Asia-Pacific Needle-free Drug Injectors Consumption Value (2020-2031)
4.5 South America Needle-free Drug Injectors Consumption Value (2020-2031)
4.6 Middle East & Africa Needle-free Drug Injectors Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
5.2 Global Needle-free Drug Injectors Consumption Value by Type (2020-2031)
5.3 Global Needle-free Drug Injectors Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
6.2 Global Needle-free Drug Injectors Consumption Value by Application (2020-2031)
6.3 Global Needle-free Drug Injectors Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
7.2 North America Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
7.3 North America Needle-free Drug Injectors Market Size by Country
7.3.1 North America Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
7.3.2 North America Needle-free Drug Injectors Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
8.2 Europe Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
8.3 Europe Needle-free Drug Injectors Market Size by Country
8.3.1 Europe Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
8.3.2 Europe Needle-free Drug Injectors Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Needle-free Drug Injectors Market Size by Region
9.3.1 Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
10.2 South America Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
10.3 South America Needle-free Drug Injectors Market Size by Country
10.3.1 South America Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
10.3.2 South America Needle-free Drug Injectors Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Needle-free Drug Injectors Market Size by Country
11.3.1 Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Needle-free Drug Injectors Market Drivers
12.2 Needle-free Drug Injectors Market Restraints
12.3 Needle-free Drug Injectors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Needle-free Drug Injectors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Needle-free Drug Injectors
13.3 Needle-free Drug Injectors Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Needle-free Drug Injectors Typical Distributors
14.3 Needle-free Drug Injectors Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Needle-free Drug Injectors Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Needle-free Drug Injectors Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Halozyme (Antares Pharma) Basic Information, Manufacturing Base and Competitors
Table 4. Halozyme (Antares Pharma) Major Business
Table 5. Halozyme (Antares Pharma) Needle-free Drug Injectors Product and Services
Table 6. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Halozyme (Antares Pharma) Recent Developments/Updates
Table 8. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Inovio Pharmaceuticals Major Business
Table 10. Inovio Pharmaceuticals Needle-free Drug Injectors Product and Services
Table 11. Inovio Pharmaceuticals Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Inovio Pharmaceuticals Recent Developments/Updates
Table 13. Endo International Basic Information, Manufacturing Base and Competitors
Table 14. Endo International Major Business
Table 15. Endo International Needle-free Drug Injectors Product and Services
Table 16. Endo International Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Endo International Recent Developments/Updates
Table 18. Injex Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 19. Injex Pharma GmbH Major Business
Table 20. Injex Pharma GmbH Needle-free Drug Injectors Product and Services
Table 21. Injex Pharma GmbH Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Injex Pharma GmbH Recent Developments/Updates
Table 23. National Medical Products (J-Tip) Basic Information, Manufacturing Base and Competitors
Table 24. National Medical Products (J-Tip) Major Business
Table 25. National Medical Products (J-Tip) Needle-free Drug Injectors Product and Services
Table 26. National Medical Products (J-Tip) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. National Medical Products (J-Tip) Recent Developments/Updates
Table 28. Recipharm Basic Information, Manufacturing Base and Competitors
Table 29. Recipharm Major Business
Table 30. Recipharm Needle-free Drug Injectors Product and Services
Table 31. Recipharm Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Recipharm Recent Developments/Updates
Table 33. InsuJet Basic Information, Manufacturing Base and Competitors
Table 34. InsuJet Major Business
Table 35. InsuJet Needle-free Drug Injectors Product and Services
Table 36. InsuJet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. InsuJet Recent Developments/Updates
Table 38. Miracle Medical Basic Information, Manufacturing Base and Competitors
Table 39. Miracle Medical Major Business
Table 40. Miracle Medical Needle-free Drug Injectors Product and Services
Table 41. Miracle Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Miracle Medical Recent Developments/Updates
Table 43. Medical International Technology (MIT) Basic Information, Manufacturing Base and Competitors
Table 44. Medical International Technology (MIT) Major Business
Table 45. Medical International Technology (MIT) Needle-free Drug Injectors Product and Services
Table 46. Medical International Technology (MIT) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Medical International Technology (MIT) Recent Developments/Updates
Table 48. Akra Dermojet Basic Information, Manufacturing Base and Competitors
Table 49. Akra Dermojet Major Business
Table 50. Akra Dermojet Needle-free Drug Injectors Product and Services
Table 51. Akra Dermojet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Akra Dermojet Recent Developments/Updates
Table 53. PharmaJet Basic Information, Manufacturing Base and Competitors
Table 54. PharmaJet Major Business
Table 55. PharmaJet Needle-free Drug Injectors Product and Services
Table 56. PharmaJet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. PharmaJet Recent Developments/Updates
Table 58. Portal Instruments Basic Information, Manufacturing Base and Competitors
Table 59. Portal Instruments Major Business
Table 60. Portal Instruments Needle-free Drug Injectors Product and Services
Table 61. Portal Instruments Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Portal Instruments Recent Developments/Updates
Table 63. Crossject Basic Information, Manufacturing Base and Competitors
Table 64. Crossject Major Business
Table 65. Crossject Needle-free Drug Injectors Product and Services
Table 66. Crossject Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Crossject Recent Developments/Updates
Table 68. Mika Medical Basic Information, Manufacturing Base and Competitors
Table 69. Mika Medical Major Business
Table 70. Mika Medical Needle-free Drug Injectors Product and Services
Table 71. Mika Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Mika Medical Recent Developments/Updates
Table 73. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Ferring Pharmaceuticals Major Business
Table 75. Ferring Pharmaceuticals Needle-free Drug Injectors Product and Services
Table 76. Ferring Pharmaceuticals Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Ferring Pharmaceuticals Recent Developments/Updates
Table 78. IntegriMedical Basic Information, Manufacturing Base and Competitors
Table 79. IntegriMedical Major Business
Table 80. IntegriMedical Needle-free Drug Injectors Product and Services
Table 81. IntegriMedical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. IntegriMedical Recent Developments/Updates
Table 83. Helcomin Basic Information, Manufacturing Base and Competitors
Table 84. Helcomin Major Business
Table 85. Helcomin Needle-free Drug Injectors Product and Services
Table 86. Helcomin Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Helcomin Recent Developments/Updates
Table 88. Nugen Medical Basic Information, Manufacturing Base and Competitors
Table 89. Nugen Medical Major Business
Table 90. Nugen Medical Needle-free Drug Injectors Product and Services
Table 91. Nugen Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Nugen Medical Recent Developments/Updates
Table 93. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 94. Lepu Medical Major Business
Table 95. Lepu Medical Needle-free Drug Injectors Product and Services
Table 96. Lepu Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Lepu Medical Recent Developments/Updates
Table 98. Beijing Quinovare Basic Information, Manufacturing Base and Competitors
Table 99. Beijing Quinovare Major Business
Table 100. Beijing Quinovare Needle-free Drug Injectors Product and Services
Table 101. Beijing Quinovare Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Beijing Quinovare Recent Developments/Updates
Table 103. Qingdao Zhonghui Health Industrial Group Basic Information, Manufacturing Base and Competitors
Table 104. Qingdao Zhonghui Health Industrial Group Major Business
Table 105. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product and Services
Table 106. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
Table 108. Global Needle-free Drug Injectors Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 109. Global Needle-free Drug Injectors Revenue by Manufacturer (2020-2025) & (USD Million)
Table 110. Global Needle-free Drug Injectors Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 111. Market Position of Manufacturers in Needle-free Drug Injectors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 112. Head Office and Needle-free Drug Injectors Production Site of Key Manufacturer
Table 113. Needle-free Drug Injectors Market: Company Product Type Footprint
Table 114. Needle-free Drug Injectors Market: Company Product Application Footprint
Table 115. Needle-free Drug Injectors New Market Entrants and Barriers to Market Entry
Table 116. Needle-free Drug Injectors Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Needle-free Drug Injectors Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 118. Global Needle-free Drug Injectors Sales Quantity by Region (2020-2025) & (K Units)
Table 119. Global Needle-free Drug Injectors Sales Quantity by Region (2026-2031) & (K Units)
Table 120. Global Needle-free Drug Injectors Consumption Value by Region (2020-2025) & (USD Million)
Table 121. Global Needle-free Drug Injectors Consumption Value by Region (2026-2031) & (USD Million)
Table 122. Global Needle-free Drug Injectors Average Price by Region (2020-2025) & (US$/Unit)
Table 123. Global Needle-free Drug Injectors Average Price by Region (2026-2031) & (US$/Unit)
Table 124. Global Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 125. Global Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 126. Global Needle-free Drug Injectors Consumption Value by Type (2020-2025) & (USD Million)
Table 127. Global Needle-free Drug Injectors Consumption Value by Type (2026-2031) & (USD Million)
Table 128. Global Needle-free Drug Injectors Average Price by Type (2020-2025) & (US$/Unit)
Table 129. Global Needle-free Drug Injectors Average Price by Type (2026-2031) & (US$/Unit)
Table 130. Global Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 131. Global Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 132. Global Needle-free Drug Injectors Consumption Value by Application (2020-2025) & (USD Million)
Table 133. Global Needle-free Drug Injectors Consumption Value by Application (2026-2031) & (USD Million)
Table 134. Global Needle-free Drug Injectors Average Price by Application (2020-2025) & (US$/Unit)
Table 135. Global Needle-free Drug Injectors Average Price by Application (2026-2031) & (US$/Unit)
Table 136. North America Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 137. North America Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 138. North America Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 139. North America Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 140. North America Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 141. North America Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 142. North America Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 143. North America Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 144. Europe Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 145. Europe Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 146. Europe Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 147. Europe Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 148. Europe Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 149. Europe Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 150. Europe Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 151. Europe Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 152. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 153. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 154. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 155. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 156. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2020-2025) & (K Units)
Table 157. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2026-2031) & (K Units)
Table 158. Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2020-2025) & (USD Million)
Table 159. Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2026-2031) & (USD Million)
Table 160. South America Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 161. South America Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 162. South America Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 163. South America Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 164. South America Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 165. South America Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 166. South America Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 167. South America Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 168. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 169. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 170. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 171. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 172. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 173. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 174. Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 175. Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 176. Needle-free Drug Injectors Raw Material
Table 177. Key Manufacturers of Needle-free Drug Injectors Raw Materials
Table 178. Needle-free Drug Injectors Typical Distributors
Table 179. Needle-free Drug Injectors Typical Customers
Table 1. Global Needle-free Drug Injectors Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Needle-free Drug Injectors Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Halozyme (Antares Pharma) Basic Information, Manufacturing Base and Competitors
Table 4. Halozyme (Antares Pharma) Major Business
Table 5. Halozyme (Antares Pharma) Needle-free Drug Injectors Product and Services
Table 6. Halozyme (Antares Pharma) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Halozyme (Antares Pharma) Recent Developments/Updates
Table 8. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 9. Inovio Pharmaceuticals Major Business
Table 10. Inovio Pharmaceuticals Needle-free Drug Injectors Product and Services
Table 11. Inovio Pharmaceuticals Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Inovio Pharmaceuticals Recent Developments/Updates
Table 13. Endo International Basic Information, Manufacturing Base and Competitors
Table 14. Endo International Major Business
Table 15. Endo International Needle-free Drug Injectors Product and Services
Table 16. Endo International Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Endo International Recent Developments/Updates
Table 18. Injex Pharma GmbH Basic Information, Manufacturing Base and Competitors
Table 19. Injex Pharma GmbH Major Business
Table 20. Injex Pharma GmbH Needle-free Drug Injectors Product and Services
Table 21. Injex Pharma GmbH Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Injex Pharma GmbH Recent Developments/Updates
Table 23. National Medical Products (J-Tip) Basic Information, Manufacturing Base and Competitors
Table 24. National Medical Products (J-Tip) Major Business
Table 25. National Medical Products (J-Tip) Needle-free Drug Injectors Product and Services
Table 26. National Medical Products (J-Tip) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. National Medical Products (J-Tip) Recent Developments/Updates
Table 28. Recipharm Basic Information, Manufacturing Base and Competitors
Table 29. Recipharm Major Business
Table 30. Recipharm Needle-free Drug Injectors Product and Services
Table 31. Recipharm Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Recipharm Recent Developments/Updates
Table 33. InsuJet Basic Information, Manufacturing Base and Competitors
Table 34. InsuJet Major Business
Table 35. InsuJet Needle-free Drug Injectors Product and Services
Table 36. InsuJet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. InsuJet Recent Developments/Updates
Table 38. Miracle Medical Basic Information, Manufacturing Base and Competitors
Table 39. Miracle Medical Major Business
Table 40. Miracle Medical Needle-free Drug Injectors Product and Services
Table 41. Miracle Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Miracle Medical Recent Developments/Updates
Table 43. Medical International Technology (MIT) Basic Information, Manufacturing Base and Competitors
Table 44. Medical International Technology (MIT) Major Business
Table 45. Medical International Technology (MIT) Needle-free Drug Injectors Product and Services
Table 46. Medical International Technology (MIT) Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Medical International Technology (MIT) Recent Developments/Updates
Table 48. Akra Dermojet Basic Information, Manufacturing Base and Competitors
Table 49. Akra Dermojet Major Business
Table 50. Akra Dermojet Needle-free Drug Injectors Product and Services
Table 51. Akra Dermojet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Akra Dermojet Recent Developments/Updates
Table 53. PharmaJet Basic Information, Manufacturing Base and Competitors
Table 54. PharmaJet Major Business
Table 55. PharmaJet Needle-free Drug Injectors Product and Services
Table 56. PharmaJet Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. PharmaJet Recent Developments/Updates
Table 58. Portal Instruments Basic Information, Manufacturing Base and Competitors
Table 59. Portal Instruments Major Business
Table 60. Portal Instruments Needle-free Drug Injectors Product and Services
Table 61. Portal Instruments Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Portal Instruments Recent Developments/Updates
Table 63. Crossject Basic Information, Manufacturing Base and Competitors
Table 64. Crossject Major Business
Table 65. Crossject Needle-free Drug Injectors Product and Services
Table 66. Crossject Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Crossject Recent Developments/Updates
Table 68. Mika Medical Basic Information, Manufacturing Base and Competitors
Table 69. Mika Medical Major Business
Table 70. Mika Medical Needle-free Drug Injectors Product and Services
Table 71. Mika Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Mika Medical Recent Developments/Updates
Table 73. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Ferring Pharmaceuticals Major Business
Table 75. Ferring Pharmaceuticals Needle-free Drug Injectors Product and Services
Table 76. Ferring Pharmaceuticals Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Ferring Pharmaceuticals Recent Developments/Updates
Table 78. IntegriMedical Basic Information, Manufacturing Base and Competitors
Table 79. IntegriMedical Major Business
Table 80. IntegriMedical Needle-free Drug Injectors Product and Services
Table 81. IntegriMedical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. IntegriMedical Recent Developments/Updates
Table 83. Helcomin Basic Information, Manufacturing Base and Competitors
Table 84. Helcomin Major Business
Table 85. Helcomin Needle-free Drug Injectors Product and Services
Table 86. Helcomin Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Helcomin Recent Developments/Updates
Table 88. Nugen Medical Basic Information, Manufacturing Base and Competitors
Table 89. Nugen Medical Major Business
Table 90. Nugen Medical Needle-free Drug Injectors Product and Services
Table 91. Nugen Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Nugen Medical Recent Developments/Updates
Table 93. Lepu Medical Basic Information, Manufacturing Base and Competitors
Table 94. Lepu Medical Major Business
Table 95. Lepu Medical Needle-free Drug Injectors Product and Services
Table 96. Lepu Medical Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Lepu Medical Recent Developments/Updates
Table 98. Beijing Quinovare Basic Information, Manufacturing Base and Competitors
Table 99. Beijing Quinovare Major Business
Table 100. Beijing Quinovare Needle-free Drug Injectors Product and Services
Table 101. Beijing Quinovare Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. Beijing Quinovare Recent Developments/Updates
Table 103. Qingdao Zhonghui Health Industrial Group Basic Information, Manufacturing Base and Competitors
Table 104. Qingdao Zhonghui Health Industrial Group Major Business
Table 105. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Product and Services
Table 106. Qingdao Zhonghui Health Industrial Group Needle-free Drug Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
Table 108. Global Needle-free Drug Injectors Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 109. Global Needle-free Drug Injectors Revenue by Manufacturer (2020-2025) & (USD Million)
Table 110. Global Needle-free Drug Injectors Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 111. Market Position of Manufacturers in Needle-free Drug Injectors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 112. Head Office and Needle-free Drug Injectors Production Site of Key Manufacturer
Table 113. Needle-free Drug Injectors Market: Company Product Type Footprint
Table 114. Needle-free Drug Injectors Market: Company Product Application Footprint
Table 115. Needle-free Drug Injectors New Market Entrants and Barriers to Market Entry
Table 116. Needle-free Drug Injectors Mergers, Acquisition, Agreements, and Collaborations
Table 117. Global Needle-free Drug Injectors Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 118. Global Needle-free Drug Injectors Sales Quantity by Region (2020-2025) & (K Units)
Table 119. Global Needle-free Drug Injectors Sales Quantity by Region (2026-2031) & (K Units)
Table 120. Global Needle-free Drug Injectors Consumption Value by Region (2020-2025) & (USD Million)
Table 121. Global Needle-free Drug Injectors Consumption Value by Region (2026-2031) & (USD Million)
Table 122. Global Needle-free Drug Injectors Average Price by Region (2020-2025) & (US$/Unit)
Table 123. Global Needle-free Drug Injectors Average Price by Region (2026-2031) & (US$/Unit)
Table 124. Global Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 125. Global Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 126. Global Needle-free Drug Injectors Consumption Value by Type (2020-2025) & (USD Million)
Table 127. Global Needle-free Drug Injectors Consumption Value by Type (2026-2031) & (USD Million)
Table 128. Global Needle-free Drug Injectors Average Price by Type (2020-2025) & (US$/Unit)
Table 129. Global Needle-free Drug Injectors Average Price by Type (2026-2031) & (US$/Unit)
Table 130. Global Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 131. Global Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 132. Global Needle-free Drug Injectors Consumption Value by Application (2020-2025) & (USD Million)
Table 133. Global Needle-free Drug Injectors Consumption Value by Application (2026-2031) & (USD Million)
Table 134. Global Needle-free Drug Injectors Average Price by Application (2020-2025) & (US$/Unit)
Table 135. Global Needle-free Drug Injectors Average Price by Application (2026-2031) & (US$/Unit)
Table 136. North America Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 137. North America Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 138. North America Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 139. North America Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 140. North America Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 141. North America Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 142. North America Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 143. North America Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 144. Europe Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 145. Europe Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 146. Europe Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 147. Europe Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 148. Europe Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 149. Europe Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 150. Europe Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 151. Europe Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 152. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 153. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 154. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 155. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 156. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2020-2025) & (K Units)
Table 157. Asia-Pacific Needle-free Drug Injectors Sales Quantity by Region (2026-2031) & (K Units)
Table 158. Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2020-2025) & (USD Million)
Table 159. Asia-Pacific Needle-free Drug Injectors Consumption Value by Region (2026-2031) & (USD Million)
Table 160. South America Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 161. South America Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 162. South America Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 163. South America Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 164. South America Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 165. South America Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 166. South America Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 167. South America Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 168. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2020-2025) & (K Units)
Table 169. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Type (2026-2031) & (K Units)
Table 170. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2020-2025) & (K Units)
Table 171. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Application (2026-2031) & (K Units)
Table 172. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2020-2025) & (K Units)
Table 173. Middle East & Africa Needle-free Drug Injectors Sales Quantity by Country (2026-2031) & (K Units)
Table 174. Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2020-2025) & (USD Million)
Table 175. Middle East & Africa Needle-free Drug Injectors Consumption Value by Country (2026-2031) & (USD Million)
Table 176. Needle-free Drug Injectors Raw Material
Table 177. Key Manufacturers of Needle-free Drug Injectors Raw Materials
Table 178. Needle-free Drug Injectors Typical Distributors
Table 179. Needle-free Drug Injectors Typical Customers
LIST OF FIGURES
Figure 1. Needle-free Drug Injectors Picture
Figure 2. Global Needle-free Drug Injectors Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Needle-free Drug Injectors Revenue Market Share by Type in 2024
Figure 4. Powder Injections Examples
Figure 5. Liquid Injections Examples
Figure 6. Depot or Projectile Injection Examples
Figure 7. Global Needle-free Drug Injectors Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Needle-free Drug Injectors Revenue Market Share by Application in 2024
Figure 9. Vaccine Delivery Examples
Figure 10. Insulin Delivery Examples
Figure 11. Others Examples
Figure 12. Global Needle-free Drug Injectors Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Needle-free Drug Injectors Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Needle-free Drug Injectors Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Needle-free Drug Injectors Price (2020-2031) & (US$/Unit)
Figure 16. Global Needle-free Drug Injectors Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Needle-free Drug Injectors Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Needle-free Drug Injectors by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Needle-free Drug Injectors Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Needle-free Drug Injectors Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Needle-free Drug Injectors Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Needle-free Drug Injectors Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Needle-free Drug Injectors Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Needle-free Drug Injectors Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Needle-free Drug Injectors Revenue Market Share by Application (2020-2031)
Figure 33. Global Needle-free Drug Injectors Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 46. France Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Needle-free Drug Injectors Consumption Value Market Share by Region (2020-2031)
Figure 54. China Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 57. India Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 74. Needle-free Drug Injectors Market Drivers
Figure 75. Needle-free Drug Injectors Market Restraints
Figure 76. Needle-free Drug Injectors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Needle-free Drug Injectors in 2024
Figure 79. Manufacturing Process Analysis of Needle-free Drug Injectors
Figure 80. Needle-free Drug Injectors Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Figure 1. Needle-free Drug Injectors Picture
Figure 2. Global Needle-free Drug Injectors Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Needle-free Drug Injectors Revenue Market Share by Type in 2024
Figure 4. Powder Injections Examples
Figure 5. Liquid Injections Examples
Figure 6. Depot or Projectile Injection Examples
Figure 7. Global Needle-free Drug Injectors Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Needle-free Drug Injectors Revenue Market Share by Application in 2024
Figure 9. Vaccine Delivery Examples
Figure 10. Insulin Delivery Examples
Figure 11. Others Examples
Figure 12. Global Needle-free Drug Injectors Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Needle-free Drug Injectors Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Needle-free Drug Injectors Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Needle-free Drug Injectors Price (2020-2031) & (US$/Unit)
Figure 16. Global Needle-free Drug Injectors Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Needle-free Drug Injectors Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Needle-free Drug Injectors by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Needle-free Drug Injectors Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Needle-free Drug Injectors Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Needle-free Drug Injectors Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Needle-free Drug Injectors Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Needle-free Drug Injectors Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Needle-free Drug Injectors Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Needle-free Drug Injectors Revenue Market Share by Application (2020-2031)
Figure 33. Global Needle-free Drug Injectors Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 46. France Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Needle-free Drug Injectors Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Needle-free Drug Injectors Consumption Value Market Share by Region (2020-2031)
Figure 54. China Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 57. India Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Needle-free Drug Injectors Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Needle-free Drug Injectors Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Needle-free Drug Injectors Consumption Value (2020-2031) & (USD Million)
Figure 74. Needle-free Drug Injectors Market Drivers
Figure 75. Needle-free Drug Injectors Market Restraints
Figure 76. Needle-free Drug Injectors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Needle-free Drug Injectors in 2024
Figure 79. Manufacturing Process Analysis of Needle-free Drug Injectors
Figure 80. Needle-free Drug Injectors Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
